These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2357214)

  • 1. Inhibition of thrombin's clotting activity by synthetic peptide segments of its inhibitors and substrates.
    Hortin GL; Benutto BM
    Biochem Biophys Res Commun; 1990 Jun; 169(2):437-42. PubMed ID: 2357214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric changes in thrombin's activity produced by peptides corresponding to segments of natural inhibitors and substrates.
    Hortin GL; Trimpe BL
    J Biol Chem; 1991 Apr; 266(11):6866-71. PubMed ID: 1849894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin activity of a peptide corresponding to residues 54-75 of heparin cofactor II.
    Hortin GL; Tollefsen DM; Benutto BM
    J Biol Chem; 1989 Aug; 264(24):13979-82. PubMed ID: 2760054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for inhibiting the effects of thrombin.
    Harker LA
    Blood Coagul Fibrinolysis; 1994 Jan; 5 Suppl 1():S47-58; discussion S59-64. PubMed ID: 8186356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural domains of thrombin involved in the induction of mitogenesis in cultured human vascular smooth muscle cells.
    Kanthou C; Dennehy U; Kakkar VV; Benzakour O
    Blood Coagul Fibrinolysis; 1995 Oct; 6(7):634-42. PubMed ID: 8562834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A player of many parts: the spotlight falls on thrombin's structure.
    Stubbs MT; Bode W
    Thromb Res; 1993 Jan; 69(1):1-58. PubMed ID: 8465268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
    Skordalakes E; Elgendy S; Goodwin CA; Green D; Scully MF; Kakkar VV; Freyssinet JM; Dodson G; Deadman JJ
    Biochemistry; 1998 Oct; 37(41):14420-7. PubMed ID: 9772168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor.
    Whinna HC; Church FC
    J Protein Chem; 1993 Dec; 12(6):677-88. PubMed ID: 8136018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dual role of thrombin's anion-binding exosite-I in the recognition and cleavage of the protease-activated receptor 1.
    Myles T; Le Bonniec BF; Stone SR
    Eur J Biochem; 2001 Jan; 268(1):70-7. PubMed ID: 11121104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crotalase, a fibrinogen-clotting snake venom enzyme: primary structure and evidence for a fibrinogen recognition exosite different from thrombin.
    Henschen-Edman AH; Theodor I; Edwards BF; Pirkle H
    Thromb Haemost; 1999 Jan; 81(1):81-6. PubMed ID: 10348716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin enhances the catalytic activity of des-ETW-thrombin.
    Goodwin CA; Deadman JJ; Le Bonniec BF; Elgendy S; Kakkar VV; Scully MF
    Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):77-83. PubMed ID: 8670135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex.
    Fuentes-Prior P; Iwanaga Y; Huber R; Pagila R; Rumennik G; Seto M; Morser J; Light DR; Bode W
    Nature; 2000 Mar; 404(6777):518-25. PubMed ID: 10761923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin.
    Maraganore JM; Bourdon P; Jablonski J; Ramachandran KL; Fenton JW
    Biochemistry; 1990 Jul; 29(30):7095-101. PubMed ID: 2223763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity.
    Liu LW; Vu TK; Esmon CT; Coughlin SR
    J Biol Chem; 1991 Sep; 266(26):16977-80. PubMed ID: 1654318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombin and its pharmacologic regulation].
    Guillin MC
    Presse Med; 1998 Jun; 27 Suppl 2():22-7. PubMed ID: 9765662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of peptide p-nitroanilides mimicking fibrinogen- and hirudin-binding to thrombin. Design of slow reacting thrombin substrates.
    Rijkers DT; Hemker HC; Tesser GI
    Int J Pept Protein Res; 1996 Aug; 48(2):182-93. PubMed ID: 8872537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin.
    Kelly AB; Maraganore JM; Bourdon P; Hanson SR; Harker LA
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6040-4. PubMed ID: 1385867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric modulation of the activity of thrombin.
    Duffy EJ; Angliker H; Le Bonniec BF; Stone SR
    Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):361-5. PubMed ID: 9020867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fibrinogen anion-binding exosite of thrombin is necessary for induction of rises in intracellular calcium and prostacyclin production in endothelial cells.
    Ngaiza JR; Manley G; Grulich-Henn J; Krstenansky JL; Jaffe EA
    J Cell Physiol; 1992 Apr; 151(1):190-6. PubMed ID: 1560043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the "tethered-ligand" receptor in thrombin inhibition of platelet adenylate cyclase.
    Seiler SM; Michel IM; Fenton JW
    Biochem Biophys Res Commun; 1992 Feb; 182(3):1296-302. PubMed ID: 1371679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.